Navigation Links
Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations
Date:5/15/2008

levels. For those patients with BMI greater than or equal to 30 kg/m(2), AZOR 10/40 mg demonstrated mean reductions of 30/18 mm Hg from an average baseline BP of 163/102 in the total cohort. Patients with BMI of less than 30 kg/m(2) saw BP reductions of 31/21 mm Hg when treated with AZOR 10/40 mg from an average baseline BP of 165/101 in total cohort.

DIABETES:

Patients with hypertension and diabetes are at greater risk of cardiovascular and renal disease and consequently have a more stringent recommended target BP goal of <130/80 mm Hg. Most patients require treatment with a combination of at least two antihypertensive agents in order to achieve their recommended goal BP, especially high-risk subgroups, and use of complementary antihypertensive drug classes is advocated in such patients.(15)(16)

Of the 1,940 patients who entered the eight week pivotal study, 261 had a medical history of diabetes. The data demonstrated the ability of AZOR to reduce blood pressure in the diabetes patient cohort. The diabetic patients treated with AZOR 10/40 mg were able to reduce their mean BP 30/18 mm Hg from an average baseline BP of 169/101 in the total cohort. This result was similar in comparison to patients without diabetes treated with AZOR 10/40 mg who were able to reduce their mean BP 30/19 mm Hg from an average baseline BP of 163/102 in the total cohort.

Important safety information

USE IN PREGNANCY

When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus. When pregnancy is detected, AZOR should be discontinued as soon as possible. See WARNINGS AND PRECAUTIONS, Fetal/Neonatal Morbidity and Mortality.

Hypotension in Volume- or Salt-Depleted Patients

In patients with an activated renin-angiotensin system, such as volume- and/or salt-depleted patients, symptomatic hypotension due particularly to the olmesa
'/>"/>

SOURCE Daiichi Sankyo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
2. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
3. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
4. Recent Studies Suggest Popular Diet Pill Relacore Reduces Acne Breakouts
5. Minimally Invasive Treatment Reduces Shoulder Pain From Tendonitis
6. Smokefree Workplace Law Reduces Heart Attacks 59% Among Nonsmokers, New Research Shows
7. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
8. CV Therapeutics Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36
9. VIA Pharmaceuticals Presents Data at American Heart Association Meeting Showing VIA-2291 Significantly Reduces Inflammation in Preclinical Model of Atherosclerosis
10. Study Finds Starion Instruments Tissue Welding Technology Reduces Pain and Bleeding in Tonsillectomy Patients
11. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... 16 RealMed has been ranked ... the 2009 Top 20 Best in ... report. RealMed is a dynamic revenue cycle ... processing between healthcare providers and all ... firm specializing in vendor performance measurement in ...
(Date:12/16/2009)... to Millennium Research Group (MRG), the global authority ... in China supported rapid expansion of the Chinese ... to fuel growth in the coming years. ... Cardiology Devices 2010 report finds that initiatives ... Chinese drug-eluting stent market to reach a value ...
(Date:12/16/2009)... -- Biovista Inc.,today announced that it was awarded ... the 2009 New England Venture Summit, held on ... cutting edge private companies,driving the future of innovation, ... other privately held companies that play a leading ... Clean-tech sectors. , "We ...
Breaking Medicine Technology:RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 2RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 3Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 2Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 3Biovista Inc. Named Top Innovator in Life Sciences 2Facet Biotech and Trubion Announce Worldwide Collaboration for the Development and Commercialization of TRU 016 55596 1Facet Biotech and Trubion Announce Worldwide Collaboration for the Development and Commercialization of TRU 016 55596 2Facet Biotech and Trubion Announce Worldwide Collaboration for the Development and Commercialization of TRU 016 55596 3Facet Biotech and Trubion Announce Worldwide Collaboration for the Development and Commercialization of TRU 016 55596 4Facet Biotech and Trubion Announce Worldwide Collaboration for the Development and Commercialization of TRU 016 55596 5Facet Biotech and Trubion Announce Worldwide Collaboration for the Development and Commercialization of TRU 016 55596 6Fast Food Choices for iPhone 28TM 29 iPod 28R 29 Touch Users With Celiac Coeliac 26 Food Allergies 55593 1Fast Food Choices for iPhone 28TM 29 iPod 28R 29 Touch Users With Celiac Coeliac 26 Food Allergies 55593 2Haven Healthcare of Utah Receives Award for Quality Care Fourth Year in a Row 55588 1Haven Healthcare of Utah Receives Award for Quality Care Fourth Year in a Row 55588 2
... ... Annually, CAMBRIDGE, Mass., Aug. 2 ... trial of Mozobil(TM),(plerixafor) has successfully met its primary and secondary endpoints,demonstrating positive ... non-Hodgkin,s lymphoma. The combined strength of these two trials -- in ...
... KING OF PRUSSIA, Pa., Aug. 2 ... experiments with its small-molecule,MIF inhibitors showed oral ... the Company announced that it is advancing ... Macrophage Migration Inhibitory Factor, or MIF, is ...
Other Medicine Technology:Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint 2Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint 3Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint 4Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint 5Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint 6Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint 7Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors 2
(Date:12/17/2009)... Researchers from the School of Sport,Exercise ... in the UK are today,encouraging families worldwide to ... following concerning research* that shows two-thirds of people,across ... family (68%), with the,Portuguese being the least likely ... , According to international ...
(Date:12/17/2009)... levels trended in 2009 and over the past three years and ... ... (Vocus) December 17, 2009 -- Morehead, the human capital research firm, ... Year in Review.” The free hour-long webinar will be broadcast ... , ,Join Rod Wilkes, M.S., Morehead’s SVP, Consulting Services and Trevor ...
(Date:12/17/2009)... reports, activity measures and outcomes reporting to monitor the impact ... costs and positive return on investment over the course of ... ... Jacksonville, FL (PRWEB) December 17, 2009 -- HealthScreen Disease Management, ... cost risk analysis along with personalized nurse care, announced today ...
(Date:12/16/2009)... If proposed health care legislation is enacted, it ... system. Approximately 18.4 million Californians and 161 million ... employer-based insurance for their health care coverage. ... legislation entail specific requirements for employer-based insurance. ... firms that currently comply with most new standards, ...
(Date:12/16/2009)... Annual Gala Raises Significant Funds to Benefit of Children ... Christine Taylor, Gary Cole and Zachary Levi Join ... ,, LOS ANGELES, Dec. 16 At its ... three remarkable individuals. Hasbro President & CEO ... Award in recognition of his far-reaching philanthropic leadership ...
Breaking Medicine News(10 mins):Health News:The Family Walk - a Dying Tradition Around the World? 2Health News:Morehead Presents Webinar on "The State of Employee Engagement: A Year in Review" 2Health News:Baptist Health System Selects HealthScreen Disease Management for Employee Health Management Services 2Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 2Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 2Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 4Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 5
... California state assembly has honored a graduate of the ... of his contribution to improving access to healthcare. ... Board (CMA), was honored with the Excellence in Medicine ... other leading Asians and Pacific Islanders were honored as ...
... a small study, vertical work-stations, incorporating a treadmill, could help obese ... ,The vertical walk and work desk allows people to ... a speed of their own choosing. ,Designed by the ... form of the alphabet H and held by four locking rubber ...
... United States, anxiety appears to increase the risk of heart attacks ... ,Coronary artery disease is caused by plaque build-up on the ... the heart. This causes them to harden and ... pain) and other serious complications. , According to a ...
... found a solution for the embarrassing problem of bad breath ... mouth paste that can tackle separate causes of smelly breath. ... as dihydrogen sulphide, which can lead to bad breath, reports ... an enzyme that fights starch and cellulose in between the ...
... are less likely to receive several types of routine ... problems , according to a RAND Corporation study issued ... women less frequently receive expensive medical care such as ... disparities in managed care settings. ,All the ...
... substances from vegetables, fruits and green tea, bring about ... the fatty acid breakdown and influence the glucose use ... protein SIRT1. ,Polyphenols are substances of plant ... to their possible health effect, polyphenols are currently sold ...
Other Medicine News:Health News:walk and Work Desk Could Help Obese Workers to Shed Weight 2Health News:Dont Worry- Be Good To Your Heart 2Health News:Women With Heart Disease and Diabetes Less Likely to Receive Proper Care: Study 2Health News:Women With Heart Disease and Diabetes Less Likely to Receive Proper Care: Study 3Health News:Intake of Polyphenol Speeds Up Fatty Acid Catabolism 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: